NVIC is sponsoring the Fifth International Public Conference on Vaccination Oct. 16-18, 2020 with the theme of “Protecting Health and Autonomy in the 21st Century.”
ABOUT THE FIFTH INTERNATIONAL PUBLIC CONFERENCE ON VACCINATION
Our conference will be professionally produced and include formal presentations and panel discussions featuring more than 40 distinguished speakers from the U.S. and other countries. Our presenters will offer their knowledge and personal experiences to empower and inspire you to make well-informed decisions about health and vaccination. The titles of presentations will be available on the conference website but speaker names will not be added to the website until shortly before the conference.
The goal of NVIC‘s 2020 conference is to provide high quality information and perspective about how industry, medical trade, academia and government impact the advancement of vaccine science, policy, law and ethics within the context of emerging medical research and how suppression of independent scientific inquiry, censorship of rational criticism and erosion of informed consent rights threaten health and human rights. This conference will celebrate freedom of thought, speech, conscience and the human right to autonomy and informed consent to medical risk taking.
You don’t want to miss the enlightened conversation about “Protecting Health and Autonomy in the 21st Century” at the Fifth International Public Conference on Vaccination Oct. 16-18, 2020.
Register today so in October you will learn how not only to survive, but to thrive, during these changing times.
Discount Ticket Pricing available for the first 1,000 Registrants
We are excited to offer the first 1,000 Registrants a Lifetime Access Ticket at a discount price! Grab yours today! The price will increase to $80 after the first 1,000 tickets are sold.
$60
THE CONTENT AND FORMAT
Featuring more than 40 selected speakers from around the world, our conference will provide attendees with a unique shared educational and networking experience over three days and nights.
The conference is divided into four main themes:
· US and International Vaccine Choice Advocacy
· Show Us the Science
· The Paradigm Shift Toward Health & Liberty
· Growing Our Grass Roots
The conference will present information and practical tools for vaccine choice advocacy no matter where you live. If you buy a lifetime ticket, will have access to this information for life!
SPEAKER PRESENTATIONS
Although the names of speakers will not be available until shortly before the conference, here is a selection of title presentations:
Aluminum Toxicity and Human Health
Redefining Vaccine Reactions to Erase Evidence Of Harm
From Masking to Mortality Rates: COVID-19 and What the Science Tells Us
The New Technologies Driving the Creation of COVID-10 Vaccines
Remembering Anthrax Vaccine: Will Coronavirus Vaccine Policy Precede the Science Again?
HPV Vaccine Ricks & Failures Are Underestimated
Manipulating Science to Endorse Policy and Market Products
Using Human Fetal Cells to Make Vaccine
Why Vaccine Mandates Violate the Ethical Principle of Informed Consent
Inflammation, Epigenetics and Autism: Lessons Learned for COVID-19 Vaccines
Why the Human Microbiome Matters
What Veterinary Science Tells Us About Pet Vaccines
Electronic Health Care Records: Tracking You From Birth to Death
Locking Down Civil Liberties in the Name of the Public Health
Why Homeschooling Is Under Attack and What You Can Do
Guarding Your Life and Your Soul
The Shrinking Medical Vaccine Exemption Handcuffs Doctors & Increases Vaccine Risks
The Physician’s Duty to First, Do No Harm
When Public Policy Invalidates Professional Judgment: A Pediatrician’s Experience
Since When Did it Become A Crime To Support the Immune System?
Censoring Freedom of Speech: If It Can Happen to Me, It Can Happen to Anyone
Vitalism and Chiropractic on the Front Lines
Grassroots Rising
Take Back Control of Your Health
Defending Life & Liberty In the Vaccine Culture War
Pharmaceutical Companies Must Be Held Legally Accountable for Vaccine Injuries & Deaths
What has Happened to the Vaccine Adverse Event Reporting System?
Mandatory Vaccination: Adults Are Next
Psychological Warfare During the COVID-19 Era
Under the Influence: The Vaccine Mandate Lobby Influencing State Legislatures
Knowledge is Power
Past is Prologue: What the History of the 1986 Act Reveals
Tyranny of the Experts: Who’s Fact Checking the Fact Checkers?
When Mother Are Silenced, Children Suffer
Walking the Highwire: You Never Walk Alone
Doctors Guilty of Medical Atrocities: Aushwitz, Tuskeegee, Willowbrook and Beyond
US Vaccine Legislation and Vaccine Freedom of Choice Advocacy
The Shunning of Nutritional Science and Self-Care in the Public COVID-19 Narrative
Editorial by Dr. Alan Palmer, Contributing Writer
[CHD Note: This is Part Three of a four-part series. In Parts One and Two I outline the case for the terrain being the most important consideration when it comes to outcomes from infectious diseases. The terrain represents the health of the individual, their nutritional status, their environmental exposures and surroundings, their access to clean water, personal and public hygiene, etc.]
Enter the spin zone
In the media coverage surrounding COVID-19, why are we hearing nothing about what each individual can do FOR THEMSELVES nutritionally in an effort to build their immune competency to resist and overcome infection? Why is the narrative all about how the pharmaceutical industry is going to “SAVE” us? Could it have something to do with the fact that the pharma-controlled media wants to convince us that we must spend billions of dollars and wait for big pharma to come to the rescue with new, expensive, proprietary and patented anti-viral drugs and a magical vaccine to rescue us from COVID-19 therefore “allowing” us to return to normal life?
I’m not even saying that it’s only nutritional options and natural alternatives that are being shunned. Even inexpensive, easy to access drugs like Hydroxychloroquine and Azithromycin with zinc are being played down, despite studies from around the world showing it’s efficacy. And, with a history of use for over 60 years in millions of people, it has proven to have an excellent safety record as compared to many other pharmaceutical drugs. A course of treatment is under $30 compared to Remdesivir, which costs more than $3,000. You can be sure that the antiviral drugs being developed for COVID-19 will probably exceed that cost. Let’s be honest; inexpensive, safe drugs or natural alternatives like herbal or nutritional compounds won’t provide pharma with the big payday they are banking on from COVID-19. They are opportunists, and you can bet they are going to make the most out of this opportunity.
No investment and all profit served up in a liability free environment! Can you think of a better business model … ?
Opportunistic organisms in biology are those parasites, bacteria, fungi, yeasts and viruses that take advantage of a weak host that offers them a ripe terrain for infection. These pharma opportunists are getting our government to fund the development and production of these drugs and vaccines to the tune of billions of dollars….AND they will potentially reap hundreds of billions of dollars in revenue from the sales (all underwritten by each of us taxpayers). No investment and all profit served up in a liability free environment! Can you think of a better business model and financial windfall scenario for them? In the meantime, as the powers that be, drag their feet on making these inexpensive treatments available to sick patients because they have something better on the horizon, thousands of people are dying. Many unnecessarily. And, since scientists have already said that the virus can and will mutate, the magical vaccine that we have all paid for and millions are relying on, will most likely be largely ineffective in a best-case scenario and outright deadly in a worst-case scenario. Another legitimate concern would be the vaccine’s role in the development of future long-term chronic disease.
A similar situation plays out every year with the flu vaccine and its miserable rate of effectiveness, because guessing which strains will be prevalent the next season to incorporate into the vaccine is a roll of the dice. Three decades of attempts to make a coronavirus vaccine have been a miserable failure, resulting in what is called “pathogenic priming” or sometimes referred to as “immune enhancement”, which is a paradoxical response. This is where a vaccinated person, after later being exposed to the same virus has the risk of acquiring an extremely exaggerated immune reaction. This is something many top scientists and doctors in the vaccine field are warning against. It is not a great scenario when they are bragging about how fast they can get these vaccines to market and taking shortcuts in the safety studies like animal safety studies, followed by long-term human trials to make it happen. Quick to market with a shell-shocked public waiting anxiously for your product. Jackpot!
… oxidative radicals wreak havoc on the body if glutathione is in short supply.
The scientific basis for nutritional effectiveness
There are thousands of studies published that demonstrate effectiveness of various natural compounds in preventing and treating viral infections. They do that in numerous ways, but the two overarching strategies is first to prime or boost the body’s own ability to attack and destroy the pathological microbes and second, to block key biochemical pathways that the virus needs to enter the cell and proliferate. In COVID-19’s case, these pathways into the cell are called the ACE-2 receptors. The cells lining the lungs and airways are particularly rich in these receptors making the lungs a receptive target for COVID-19. Nutritional compounds can also effectively manage the high levels of inflammation and collateral damage caused by the infection, which is one of the main reasons the COVID-19 infection can reach catastrophic levels and, in some cases becomes fatal. Many reports have discussed a phenomenon that can occur called a “cytokine storm”, which is an example of an out of control inflammatory immune reaction throughout the body. The oxidative stress from this reaction causes massive collateral tissue damage. Incidentally, the cytokine storm phenomenon is not new or unique to COVID-19. The literature is replete with studies discussing it in relationship to severe influenza as well.
One example of a nutritional superhero is glutathione. Glutathione the body’s “Master Antioxidant”, is essential for successfully fighting infection and mitigating the damaging effects of the production of oxidative free radicals that are released during infection. These oxidative radicals wreak havoc on the body if glutathione is in short supply. These oxidative free-radicals are now implicated in the cause of the cytokine storm that often results in the loss of life from COVID-19. Fortunately, there are ways that you can boost your own glutathione levels. Therefore, reducing inflammation and oxidative stress naturally not only decreases the severity of the infection and risk of death, but also the long-term health altering after-effects post infection.
N-Acetyl-Cysteine or N.A.C., is another important and related compound. Studies have also shown that taking N.A.C. will not only help boost glutathione levels but may also help to prevent the formation of what is called von Willebrand Factor, an agent that is responsible for the blood clotting problems that frequently develops in COVID-19 patients.
The incredible partnership between the miraculous human immune system and nature
The biochemistry of how the intelligence of the body operates is truly remarkable. And the immune system is a symphony of players that when all working properly and in concert, make beautiful music together. Beautiful unless you are a pathogen. When working in harmony, the different players in the immune system are truly a formidable force to be reckoned with. They seek, identify and destroy the intruder. Rather than using a drug that often has risks of side effects to “kill” the infection, this approach fortifies and builds the body’s own defenses and mechanisms to fight the offending microbe and then clean up the mess and debris afterwards. This includes upregulating white blood cells and immune regulatory players like macrophages, natural killer cells (NK cells), neutrophils and monocytes. As an example, vitamin C greatly increases numbers, activity and effectiveness of macrophages, NK cells, neutrophils and monocytes. Human beings can’t make our own, so we have to get it from diet and supplementation. Vitamin C demands increase substantially during times of stress, injury and infection. Therefore, it is essential to meet those demands with increased consumption when you want your immune system to work at it’s best.
A macrophage grabbing and engulfing a pathogen
Another example of key players during infection are cytokines. Cytokines are proteins that act as cell signaling agents. Some cytokines are pro-inflammatory, and some are anti-inflammatory in action. Some pro-inflammatory response is necessary and appropriate during infection, but it needs to be kept in check to prevent raging inflammation or even an autoimmune shift causing the immune system to attack the body’s own tissues. Various natural compounds are shown to regulate these processes and keep them in balance, preventing damaging downstream effects. Those compounds include fish oil, curcumin (the active ingredient in turmeric), vitamin D, resveratrol and quercetin among others.
We will look further into the way the immune system combats infection and ways to optimize its function in the final segment of this four-part series.
Dr. Palmer’s free eBook 1200 Studies – Truth Will Prevail, now 730 pages long, includes over 1400 published studies – authored by thousands of scientists and researchers – that contradict what officials are telling the public about vaccine safety and efficacy. It has easy search and navigation features including links to article abstracts and studies on PubMed or the source journal that make it an invaluable research and reference tool. Download it free at www.1200studies.com
I must admit the current attitude of our ‘authorities’ to just slap a face mask on really gets under my skin, when there are so many helpful, productive things people can do to strengthen their immune systems. They are majoring on the minors and minoring on the majors.
The key to fighting illness has always been and will always be in making yourself a tough target.
The recent publications of the (placebo-less) phase I clinical trial of Moderna’s mRNA-1273 (COVID-19) vaccine, followed by the animal study in monkeys, both in the prestigious New England Journal of Medicine, have propelled the vaccine into the final phase III clinical trial.
This must be a good development for the company, right? But wait… as reported by The Jerusalem Post on August 2, 2020, Moderna’s Chief Medical Officer Tal Zaks just sold almost all of his shares of the company’s stock, raising concerns about his trust in the vaccine:
“In general, when stakeholders believe in their product, they increase their shares in order to increase confidence in the market. The move by Moderna officials to do the opposite raised concerns about the company, especially considering that Zaks, who sold almost all of his shares, is on the scientific side of the company, according to Globes.”
We won’t ever know what was left unpublished that motivated such a step by Moderna’s Chief Medical Officer, but let’s take a look at what is published and may end up being problematic for vaccine safety and effectiveness.
First, both in the animal study and in phase I clinical trial, the COVID-19 mRNA vaccination generated much higher antibody titers than those generated after natural SARS-CoV-2 infections. Why would that be a problem? Don’t we want high antibody titers for better protection—the higher, the better? Not always.
Low levels of antibody production to some viral infections might be Mother Nature’s way to limit the effects of potential cross-priming and virally-induced autoimmunity, where such possibility exists. The possibility is present for SARS-CoV-2. Lyons-Weiler and Kanduc have independently published their biocomputational analyses of cross-reactive epitopes between SARS-CoV-2 and human proteins. If antibodies to these epitopes are produced at higher than natural levels, it may spur autoimmunity.
In the past, Kanduc & Shoenfeld made a similar biocomputational discovery of cross-reactivity between HPV (human papillomavirus) antigens and human self-antigens. Natural HPV infections generate low levels of antibodies, whereas the HPV vaccine (Gardasil) generates much higher levels. And while natural HPV infections are not accompanied by medical complaints of autoimmunity, there are plenty of such complaints in VAERS after the receipt of the HPV vaccine, and with statistically higher odds than after other vaccines, per this study.
Second, by the time Moderna’s vaccine could become available, a significant percentage of the population might have already had an asymptomatic or mild infection with the SARS-CoV-2 virus, which was not diagnosed. A recent study showed that 70% of those who had COVID-19 and even 20% of whose who were not known to be exposed, had CD8 T-cells that recognized SARS-CoV-2-specific epitopes.
CD8 T-cells are known as T killer cells. When reactivated by antigen re-exposure, they are capable of rapidly killing the cells that harbor that antigen. Getting the mRNA vaccine without knowing one’s history of a prior SARS-CoV-2 infection (especially when asymptomatic or undiagnosed), and without screening out those with pre-existing SARS-CoV-2-specific CD8 T-cells, is of grave concern.
Why? Because after being injected, the mRNA vaccine is incorporated into muscle cells, and some of it diffuses and gets into distant tissues and organs, such as bone marrow, spleen, liver, and even testes, as found in this mouse study, using never-licensed influenza mRNA vaccine candidate.
Therefore, once the COVID-19 mRNA vaccine gets expressed in various cells and tissues of vaccine recipients who have previously had a natural infection, their SARS-CoV-2-specific T killer cells may get reactivated and damage those tissues and organs. Are we ready to play Russian roulette with our immune systems?
Last, but not least, mRNA vaccine technology is known to generate waning antibody responses in a long term. For example, a study of another never-licensed rabies mRNA vaccine candidate showed that “after the initial vaccinations, 17 out of 21 participants had titers of 0.5 IU/mL or more 4 weeks after priming, but 1 year later, only two of the 14 who returned still had detectable antibodies, and neither had a titer of 0.5 IU/mL or more.”
The COVID-19 mRNA vaccine trial volunteers have not yet been titer-tested after one year. And after they do, get ready to be told we need annual boosters.
Even in a shorter time frame, the nasal infection in the monkeys was not completely blocked by low vaccination dose of the COVID-19 mRNA vaccine. The high vaccination dose (which had much higher reactogenicity in human volunteers in phase I trial) did prevent viral replication in monkeys’ noses. But since viral challenge of animals was performed at the optimal time (4 weeks following vaccination series), the results may not be representative of a real world scenario, where viral exposure is not so perfectly timed with the peak of antibody production.
In summary, with serious gaps in published vaccine assessment, Moderna’s mRNA-1273 vaccine will likely fall short of delivering the long-awaited safe and effective reprieve from the COVID-19 fear narrative.
________________________________ Tetyana Obukhanych, Ph.D. is Immune Science Educator at BBCH (Building Bridges in Children’s Health), an online community of parents and doctors dedicated to learning the science that impacts children’s health and committed to the principle of informed medical consent.
_______________________
**Comment**
The following statement should be familiar to Lyme/MSIDS patients:
Getting the mRNA vaccine without knowing one’s historyof a prior SARS-CoV-2 infection (especially when asymptomatic or undiagnosed), and without screening out those with pre-existing SARS-CoV-2-specific CD8 T-cells, is of grave concern.
Infectious: Can dogs and cats transmit SARS-CoV-2 to people?
“Currently, there is no evidence that animals are playing a significant epidemiological role in the spread of human infections with SARS-CoV-2.” OIE. Evidence of transmission from dogs or cats to people would require clarity on two factors; timing and other transmission routes. A person would need to become sick with COVID-19 after their dog or cat had shown signs of infection AND all other possible routes of transmission from people would need to be excluded. Because they are in contact with many more dogs and cats than most people, veterinarians and shelter workers would be most at risk for this kind of transmission. Thankfully, there appears to be no greater prevalence of COVID-19 in these workforces.
With over 4 million human cases worldwide we have an abundance of complex, uncontrolled but undeniably valuable epidemiological evidence about transmission. The extremely small number of infections from people to dogs and cats, and the lack of any examples of transmission to people, is meaningful.
Dogs and cats are not playing a role in transmission of SARS-CoV-2 to people.
These companion animals are the victims of this reverse zoonosis; they are (rarely) infected but not infectious.
Schoolyards and suburban parks are two environments where active tick surveillance may inform local management approaches. Even in a state such as New York with a robust active tick surveillance programme operated by the state Department of Health, these settings are not routinely covered. The goal of this study was to highlight the importance of active surveillance for tick-borne pathogens by describing their prevalence in ticks collected from schoolyards and suburban parks and to guide the use of integrated pest management in these settings. Tick dragging was performed in three regions of New York State: Long Island, the Lower Hudson Valley and the Capital Region. A total of 19 schoolyards and 32 parks were sampled. The location, habitat and weather at the time of tick collection were recorded. Ticks were speciated and tested for the presence of 17 pathogens with a novel application of nanoscale real-time PCR.
The causative agents of Lyme disease, anaplasmosis, babesiosis and Powassan virus disease were all detected from Ixodes scapularis in various sites throughout the capital region and south-eastern counties of New York state.
The most common agent detected was Borrelia burgdorferi
coinfection rates were as high as 36%
This surveillance study also captured the first of the invasive Asian longhorned tick species,Haemaphysalis longicornis, in New York state (collected 2 June 2017).
Results from this study highlight the importance of collaborative efforts and data sharing for improvement of surveillance for tick-borne disease agents.
___________________
**Comment**
This study doesn’t surprise me one bit. New York is a hot-zone and it only follows that parks and schoolyards would be prime tick locations. Here in Wisconsin, they’ve found ticks even in shortly cut grassy playing fields that school children use. They aren’t just in the shrubby and wooded areas commonly thought of.
Lastly, this study shows the importance of coinfection as 36% of ticks were infected with more than one pathogen. ‘Authorities’ have not dealt with this crucial issue that’s affecting many patients and the need for them to rethink and revise their ‘guidelines’ that they’ve left virtually untouched for over 40 years. Treatment is far more complex than they are admitting to: https://madisonarealymesupportgroup.com/category/lyme-disease-treatment/
